Management tracks: bluebird's Walsh departing as chief strategy officer; plus JDRF, Akcea, Rigel, Elicio and Progenity

bluebird bio Inc. (NASDAQ:BLUE) Chief Strategy Officer Jeffrey Walsh will step down, effective Jan. 6, 2020. The gene therapy company said CFO Chip Baird and CBO Joanne

Read the full 270 word article

How to gain access

Continue reading with a
two-week free trial.